Patent · US Active

Protease inhibitors

US11312693B2 · kind B2 · utility

0Cited by

8References

3Claims

0Family size

Assignee

MEDIVIR AB · SE

Inventors

Lourdes Salvador ODEN · Huddinge, SE
Magnus Nilsson · Mölndal, SE
Pia Kahnberg · Huddinge, SE
Bertil Samuelsson · Huddinge, SE
Urszula Grabowska · Huddinge, SE

Key dates

Filing date	Jul 27, 2020
Grant date	Apr 26, 2022
Priority date	—
Expiry date	Jul 27, 2040

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of the formula II: wherein

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.